{"id":"https://openalex.org/W1586690832","doi":"https://doi.org/10.1161/circ.116.suppl_16.ii_813","title":"Abstract 3589: Warfarin Therapy, Anticoagulation Intensity and Outcomes in Older vs. Younger Patients with Atrial Fibrillation: The ATRIA Study","display_name":"Abstract 3589: Warfarin Therapy, Anticoagulation Intensity and Outcomes in Older vs. Younger Patients with Atrial Fibrillation: The ATRIA Study","publication_year":2007,"publication_date":"2007-10-16","ids":{"openalex":"https://openalex.org/W1586690832","doi":"https://doi.org/10.1161/circ.116.suppl_16.ii_813","mag":"1586690832"},"language":"en","primary_location":{"id":"doi:10.1161/circ.116.suppl_16.ii_813","doi":"https://doi.org/10.1161/circ.116.suppl_16.ii_813","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.116.suppl_16.ii_813","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026846209","display_name":"Alan S. Go","orcid":"https://orcid.org/0000-0001-9109-0811","observed_orcids":["https://orcid.org/0000-0001-9109-0811","https://orcid.org/0000-0001-5671-0763"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan S Go","raw_affiliation_strings":["Kaiser Permanente of Northern Calif, Oakland, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente of Northern Calif, Oakland, CA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055666587","display_name":"Margaret C. Fang","orcid":"https://orcid.org/0000-0003-3362-1543","observed_orcids":["https://orcid.org/0000-0003-3362-1543"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret C Fang","raw_affiliation_strings":["Univ of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050981927","display_name":"Yuchiao Chang","orcid":"https://orcid.org/0000-0003-1093-3755","observed_orcids":["https://orcid.org/0000-0003-1093-3755"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuchiao Chang","raw_affiliation_strings":["Massachusetts General Hosp, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hosp, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024099354","display_name":"Leila H. Borowsky","orcid":"https://orcid.org/0000-0001-7498-4450","observed_orcids":["https://orcid.org/0000-0001-7498-4450"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leila H Borowsky","raw_affiliation_strings":["Massachusetts General Hosp, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hosp, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047189658","display_name":"Niela K. Pomernacki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niela K Pomernacki","raw_affiliation_strings":["Kaiser Permanente of Northern Calif, Oakland, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente of Northern Calif, Oakland, CA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020290782","display_name":"Daniel E. Singer","orcid":"https://orcid.org/0000-0001-6145-4848","observed_orcids":["https://orcid.org/0000-0001-6145-4848"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel E Singer","raw_affiliation_strings":["Massachusetts General Hosp, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hosp, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"116","issue":"suppl_16","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anticoagulation-intensity","display_name":"anticoagulation intensity","score":0.9240000247955322},{"id":"https://openalex.org/keywords/inr-target-range","display_name":"INR target range","score":0.8209999799728394},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.5740000009536743},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.7710000276565552},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.9789999723434448},{"id":"https://openalex.org/keywords/thromboembolism","display_name":"thromboembolism","score":0.9449999928474426},{"id":"https://openalex.org/keywords/age-differences","display_name":"age differences","score":0.6179999709129333},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.6100000143051147},{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.980158805847168},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8714227676391602},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8504720330238342},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6337819695472717},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5369783043861389},{"id":"https://openalex.org/C142454548","wikidata":"https://www.wikidata.org/wiki/Q7069573","display_name":"Number needed to harm","level":5,"score":0.5112767219543457},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.47084924578666687},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.45333796739578247},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.43116897344589233},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3714095950126648},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.350273996591568},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3468819558620453},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3343410789966583},{"id":"https://openalex.org/C67774102","wikidata":"https://www.wikidata.org/wiki/Q614132","display_name":"Number needed to treat","level":4,"score":0.25181835889816284},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.116.suppl_16.ii_813","doi":"https://doi.org/10.1161/circ.116.suppl_16.ii_813","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.116.suppl_16.ii_813","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049678037","https://openalex.org/W2366575396","https://openalex.org/W1678979958","https://openalex.org/W1973178409","https://openalex.org/W2082168979","https://openalex.org/W2602216696","https://openalex.org/W1494731584","https://openalex.org/W1977016143","https://openalex.org/W2074119210","https://openalex.org/W6911390514"],"abstract_inverted_index":{"Background.":[0],"Warfarin":[1],"is":[2,281],"highly":[3],"efficacious":[4],"for":[5,104,219,252],"stroke":[6,105,172],"prevention":[7,295],"in":[8,12,30,38,86,184],"atrial":[9],"fibrillation":[10],"(AF)":[11],"selected":[13],"randomized":[14],"trial":[15],"populations.":[16],"However,":[17],"controversy":[18],"exists":[19],"about":[20],"its":[21],"effectiveness":[22,216],"and":[23,25,33,67,82,88,106,112,117,127,166,173,201,223,235,254],"safety":[24],"the":[26,31,180,214,248,267,282,288],"target":[27,284],"INR":[28,83,100,186,244,278],"range":[29,187,286],"old":[32,35],"oldest":[34],"AF":[36,57],"patients":[37,55,159],"usual":[39],"clinical":[40,111,269],"care.":[41],"Methods.":[42],"We":[43,197],"examined":[44],"anticoagulation-related":[45],"outcomes":[46],"associated":[47],"with":[48,56,210,264],"older":[49,144,211,276],"vs.":[50],"younger":[51],"age":[52,191,259,291],"among":[53],"13,559":[54],"within":[58],"Kaiser":[59],"Permanente":[60],"of":[61,136,171,182,217,271,290,300],"Northern":[62],"California":[63],"between":[64,230],"July":[65],"1996":[66],"September":[68],"2003.":[69],"Longitudinal":[70],"warfarin":[71,178,218,272],"use":[72],"was":[73,93,141,188,273],"characterized":[74,94],"using":[75,95],"a":[76,138,168],"validated":[77,198],"algorithm":[78],"from":[79,98,110,124],"filled":[80],"prescriptions":[81],"tests":[84],"found":[85],"pharmacy":[87],"lab":[89],"databases.":[90,114],"Anticoagulation":[91],"intensity":[92],"linear":[96],"interpolation":[97],"outpatient":[99],"tests.":[101],"Risk":[102],"factors":[103],"bleeding":[107,174],"were":[108,122,160,208],"obtained":[109],"administrative":[113],"Thromboembolic":[115],"(TE)":[116],"intracranial":[118],"hemorrhage":[119],"(ICH)":[120],"events":[121,256],"identified":[123],"hospitalization":[125],"databases":[126],"confirmed":[128],"by":[129,143],"chart":[130],"review.":[131],"Results.":[132],"During":[133],"66,754":[134],"person-years":[135],"follow-up,":[137],"large":[139],"fraction":[140],"contributed":[142],"patients:":[145],"<60":[146],"(12.3%),":[147],"60":[148,232],"\u2013":[149,194,233],"69":[150,234],"(18.5%),":[151],"70":[152],"\u201379":[153],"(37.8%),":[154],"80+":[155,236],"(31.4%)":[156],"years.":[157],"Older":[158],"more":[161],"likely":[162],"to":[163,227,292],"be":[164],"women":[165],"have":[167],"higher":[169,209],"prevalence":[170],"risk":[175,299],"factors.":[176],"Among":[177,262],"users,":[179],"proportion":[181],"time":[183],"therapeutic":[185],"similar":[189],"across":[190,257,287],"groups":[192],"(64":[193],"66%,":[195],"P=NS).":[196],"1041":[199],"TE":[200,221,253,294],"279":[202],"ICH":[203,228,255],"events.":[204],"Absolute":[205],"event":[206],"rates":[207],"age,":[212],"but":[213],"relative":[215,224],"preventing":[220],"increased":[222],"harm":[225],"due":[226],"decreased":[229],"ages":[231],"years":[237],"(Table":[238],").":[239],"In":[240],"separate":[241],"multivariable":[242],"analyses,":[243],"2.0":[245,279],"\u20133.0":[246,280],"provided":[247],"optimal":[249,283],"risk-benefit":[250],"ratio":[251],"each":[258],"category.":[260],"Conclusion.":[261],"persons":[263],"nonvalvular":[265],"AF,":[266],"net":[268],"benefit":[270],"greater":[274],"at":[275,296],"ages.":[277],"anticoagulation":[285],"spectrum":[289],"maximize":[293],"an":[297],"acceptable":[298],"ICH.":[301]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}